Heart-Lung Support and Fluid Response Study
Part of Infections, Lungs & breathing clinical trials.
This study watches how your body responds to fluids while on VA ECMO (a heart-lung machine). The goal is to improve care for people needing this support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently receiving VA ECMO life support for your heart and lungs.
- You are between 18 and 75 years old.
- You are not pregnant.
- You can safely have your legs raised as part of a test (no recent leg, back, or head injuries, and no open abdomen).
- You have not had a stroke in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how doctors can monitor your blood flow and fluid needs while you are on VV-ECMO. It involves a simple maneuver where your legs are raised to see if your heart needs more fluid.
This trial tests a simple bedside test (raising your legs and giving a small amount of fluid) to see how well your heart responds. It is for patients in the ICU with vasodilatory shock and severe lung injury who are on a ventilator.
This study tests a personalized breathing technique to improve lung function and heart performance in children who have had heart surgery or are on ECMO. The goal is to find the best way to open up the lungs safely.
This trial looks at using a specific heart-lung support machine (the EUROSETS ECMOLIFE system) for adults who need urgent “extra” circulation support. It may help clinicians understand how well the device works in serious situations like shock, cardiac arrest, or after heart surgery.
This study looks at ways to improve breathing and blood flow in patients who are on a heart-lung machine (ECMO) for severe heart problems. It may help doctors better manage care for people in intensive care.
This study looks at how the immune system and ECMO (a machine that helps oxygenate blood) can improve outcomes for people with moderate to severe ARDS. If you join, researchers will monitor your condition and treatment to find better ways to manage this serious lung problem.
Hear when a new ECMO Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.